Gb virus c (hepatitis g virus) for the treatment of hiv
AssigneesUniversity of Iowa Research Foundation, The United States of America as represented by the Secretary of the Department of Veterans Affairs
InventorsJACK T. STAPLETON, Jinhua Xiang, Donna Klinzman, James H. McLinden
Life of this patent
Estimating the term…
Abstract
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.
Claims14
1-8. (canceled)
A method for preventing or treating HIV infection comprising administering to a subject a composition comprising a GBV-C peptide binding agent, wherein the binding agent attenuates HIV infectivity.
21-40. (canceled)
Dependencies are inferred from the claim text.